Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Opioid-free analgesia in intensive care unit
2022-003273-37Phase 4Active
- Sponsor
- CHU Nîmes
- Start
- Oct 2022
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of remifentanil, acetaminophen, ketamine, nefopam and tramadol in pain, critical illness and acute respiratory decompensation, sponsored by CHU Nîmes. Started Oct 2022; status: active.
02
Drugs
remifentanilacetaminophenketaminenefopamtramadol
03
Conditions
paincritical illnessacute respiratory decompensation
Beyond the preview
Go deeper on 2022-003273-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-003273-37.